InvestorsHub Logo
Followers 5
Posts 86
Boards Moderated 0
Alias Born 07/06/2015

Re: None

Thursday, 09/24/2015 8:48:39 AM

Thursday, September 24, 2015 8:48:39 AM

Post# of 15766
"We also look forward to discussing our ongoing activities to prepare for vepoloxamer's New Drug Application and our commercialization plans for vepoloxamer in sickle cell disease."

http://finance.yahoo.com/news/mast-therapeutics-host-analyst-investor-120000396.html

Why has he gone DIRECT to making public comments about preparing the NDA and commercialization and skipping EPIC? He doesn't even say preparing the NDA "IF" EPIC is a success. BTW, The lawyers had to sign off on this PR.

BlinkX90